X
Please Wait
Applying Filters...
01 RUXOLITINIB PHOSPHATE (5)
01 INCYTE CORP (5)
01 TABLET;ORAL (5)
01 EQ 10MG BASE (1)
02 EQ 15MG BASE (1)
03 EQ 20MG BASE (1)
04 EQ 25MG BASE (1)
05 EQ 5MG BASE (1)
01 USA (5)
19
Incyte Corporation, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is RUXOLITINIB PHOSPHATE, with a corresponding application number 202192 and regulatory information .
proudly manufactured in the
approval since 2011-11-16
Incyte Corporation's JAKAFI TABLET;ORAL, medication with EQ 20MG BASE of RUXOLITINIB PHOSPHATE.
18
Incyte Corporation, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is RUXOLITINIB PHOSPHATE, with a corresponding application number 202192 and regulatory information .
proudly manufactured in the
approval since 2011-11-16
Incyte Corporation's JAKAFI TABLET;ORAL, medication with EQ 10MG BASE of RUXOLITINIB PHOSPHATE.
17
Incyte Corporation, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is RUXOLITINIB PHOSPHATE, with a corresponding application number 202192 and regulatory information .
proudly manufactured in the
approval since 2011-11-16
Incyte Corporation's JAKAFI TABLET;ORAL, medication with EQ 25MG BASE of RUXOLITINIB PHOSPHATE.
16
Incyte Corporation, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is RUXOLITINIB PHOSPHATE, with a corresponding application number 202192 and regulatory information .
proudly manufactured in the
approval since 2011-11-16
Incyte Corporation's JAKAFI TABLET;ORAL, medication with EQ 15MG BASE of RUXOLITINIB PHOSPHATE.
15
Incyte Corporation, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is RUXOLITINIB PHOSPHATE, with a corresponding application number 202192 and regulatory information .
proudly manufactured in the
approval since 2011-11-16
Incyte Corporation's JAKAFI TABLET;ORAL, medication with EQ 5MG BASE of RUXOLITINIB PHOSPHATE.
Market Place
